Benzinga - Fri, 16 Apr 2021 08:10:46 -0400
Benzinga - Wed, 07 Apr 2021 16:08:14 -0400
Benzinga - Wed, 07 Apr 2021 16:07:43 -0400
load more
Sector: Health Care.Industry: Biotechnology
Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-03
REV
Q4 2020Est.ActualSurprise
EPS-1.240
REV827.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KDNYChinook Therapeutics-5.57%689.1M

Chinook Therapeutics Company Questions & Answers

Q

How do I buy Chinook Therapeutics (KDNY) stock?

A

You can purchase shares of Chinook Therapeutics (NASDAQ: KDNY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Chinook Therapeutics's (KDNY) main competitors?

A

Other companies in Chinook Therapeutics’s space includes: Avidity Biosciences (NASDAQ:RNA), TCR2 Therapeutics (NASDAQ:TCRR) and Syndax Pharmaceuticals (NASDAQ:SNDX).

Q

What is the target price for Chinook Therapeutics?

A

The latest price target for Chinook Therapeutics (NASDAQ: KDNY) was reported by Wedbush on 2021-01-06. The analyst firm set a price target for 28.00 expecting KDNY to rise to within 12 months (a possible 72.20% upside). 5 analyst firms have reported ratings in the last year.

Q

How much is Chinook Therapeutics (KDNY) stock ?

A

The stock price for Chinook Therapeutics (NASDAQ: KDNY) is $16.26 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Chinook Therapeutics (KDNY) dividend?

A

There are no upcoming dividends for Chinook Therapeutics.

Q

When is Chinook Therapeutics (NASDAQ:KDNY) reporting earnings?

A
Chinook Therapeutics’s Q1 earnings are confirmed from now on August 3, 2021.
Q

When is the upcoming split for KDNY?

A

There is no upcoming split for Chinook Therapeutics.